SOLASCURE
SolasCure aims to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds.
SOLASCURE
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2017-06-20
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.solascure.com
Total Employee:
11+
Status:
Active
Contact:
+441223827959
Total Funding:
20.77 M USD
Technology used in webpage:
IPv6 Google Apps For Business Gravatar Profiles Google DNS Google Domains Google Cloud DNS
Similar Organizations
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Current Advisors List
Board_observer
2018-08-01
Board_observer
2019-01-01
Current Employees Featured
Aurelie Bouzelmat Chief Development Officer @ SolasCure
Chief Development Officer
2020-04-01
Bela Kelety Chief Technology Officer @ SolasCure
Chief Technology Officer
2018-07-01
Benjamin Newmark President & CFO @ SolasCure
President & CFO
2017-06-20
David G. CMO @ SolasCure
CMO
2018-10-01
Sam Bakri Chairman and Founder @ SolasCure
Chairman and Founder
2015-09-01
Founder
Investors List
Jonathan Milner
Jonathan Milner investment in Series A - SolasCure
François Fournier
François Fournier investment in Series A - SolasCure
Development Bank of Wales
Development Bank of Wales investment in Series A - SolasCure
Seneca Partners
Seneca Partners investment in Series A - SolasCure
Bionova Capital
Bionova Capital investment in Series A - SolasCure
Eva Pharma
Eva Pharma investment in Series A - SolasCure
BRAIN
BRAIN investment in Series A - SolasCure
BRAIN
BRAIN investment in Seed Round - SolasCure
Official Site Inspections
http://www.solascure.com Semrush global rank: 6.42 M Semrush visits lastest month: 378
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "SolasCure"
HOME | SolasCure
By submitting this message I consent to share my name and email address with SolasCure. Change is needed in current health systems. Patients, practitioners, and regulators across the …See details»
ABOUT US - SolasCure
With more than 20 years of both strategic and operational experience in clinical research and development of pharmaceuticals and medical devices, Antoinette brings a deep understanding …See details»
SolasCure - Crunchbase Company Profile & Funding
Organization. SolasCure . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
SolasCure - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
SolasCure 2025 Company Profile: Valuation, Funding
SolasCure General Information Description. Developer of hydrogel designed to treat patients with chronic wounds. The company's hydrogel contains a …See details»
CONTACT - SolasCure
By submitting this message I consent to share my name and email address with SolasCure Wellington House, East Road, Cambridge, Cambridgeshire, CB1 1BH +44 1223 827 959See details»
SolasCure Company Profile - Office Locations, Competitors ... - Craft
SolasCure (also known as AURASE) is a biotech company engaged in the development of healthcare products. It leverages biomimicry and evidence-based medicine to develop …See details»
SolasCure - Contacts, Employees, Board Members, Advisors
Transforming chronic wound care with breakthrough enzymatic technologySee details»
Solascure Limited Company Information - Funding, Investors, and …
Solascure Limited is a treatment for patients with chronic wounds founded in 2017. Seedtable Score 76 Startups. 1. Funding Rounds. $1.6m. Money raised. About; Insights; Fundings; …See details»
SolasCure - VentureRadar
Our proprietary technology leverages biomimicry and evidence-based medicine to develop treatments for patients with chronic wounds. ... Find out more about SolasCure, …See details»
Solascure - Alien Technology Transfer
In response, SolasCure is in the process of developing Aurase Wound Gel, an investigational product. This hydrogel incorporates a highly-specific enzyme derived from and cloned from medical maggots. The medical application of …See details»
SolasCure - Products, Competitors, Financials, Employees, …
SolasCure collaborates with USAISR for combat wound care The collaboration between the two will assess the potential of SolasCure’s Aurase wound gel in combat situations using non …See details»
Company Spotlight: Solascure - SyndicateRoom
Apr 29, 2022 # Solascure - up 66% ### In brief - SolasCure has initiated its Phase 2a trial in the US, UK and Hungary and has treated its first patient. - Awarded best-in-laboratory-science …See details»
NEWS - SolasCure
Aug 21, 2024 Harnessing the power of maggots: Cambridge biologics company SolasCure is developing an accessible method for cleaning chronic wounds, inspired by nature’s solution. …See details»
SolasCure - Overview, News & Similar companies | ZoomInfo.com
Dec 12, 2023 Who is SolasCure. Founded in 2017, based out of United Kingdom, SolasCure Limited aims to support healthcare professionals with wound care products that significantl y …See details»
SolasCure receives £15m investment - Lifescience Industry News
Aug 13, 2021 SolasCure is developing proprietary technology leveraging biomimicry and evidence-based medicine to empower health care professionals to treat patients with chronic …See details»
SolasCure collaborates to test Aurase Wound Gel
Nov 14, 2024 Biotechnology company SolasCure has collaborated with the United States Army Institute of Surgical Research (USAISR) to evaluate how SolasCure’s product Aurase Wound …See details»
AURASE WOUND GEL | SolasCure
By submitting this message I consent to share my name and email address with SolasCure. Evidence of effective debridement. Dose dependent debridement observed in patients with ≥ …See details»
SolasCure (@SolasCure) - Twitter
Dec 16, 2021 The latest Tweets from SolasCure (@SolasCure). Revolutionising wound care with biomimicry and evidence-based medicineSee details»
SolasCure Publishes Phase IIa Clinical Trial Report in Leading …
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, has today announced the publication of its CLEANVLU Phase …See details»